TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Companion Animal Specialty Drugs Market Research Report 2023

Global Companion Animal Specialty Drugs Market Research Report 2023

  • Category:Life Sciences
  • Published on : 13 December 2022
  • Pages :86
  • Formats:
  • Report Code:SMR-7508130
OfferClick for best price

Best Price: $2320

Companion Animal Specialty Drugs Market Size, Share 2022


Market Analysis and Insights: Global Companion Animal Specialty Drugs Market

The global Companion Animal Specialty Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Companion Animal Specialty Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Companion Animal Specialty Drugs market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Companion Animal Specialty Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Companion Animal Specialty Drugs market.

Global Companion Animal Specialty Drugs Scope and Market Size

Companion Animal Specialty Drug is a kind of veterinary drugs that pet owners used to treatment and care of animals.

Due to the COVID-19 pandemic, the global Companion Animal Specialty Drugs market size is estimated to be worth US$ 12530 million in 2022 and is forecast to a readjusted size of US$ 17200 million by 2030 with a CAGR of 4.6% during the forecast period 2023-2030. Fully considering the economic change by this health crisis, the Europe Companion Animal Specialty Drugs market is estimated at US$ million in 2023, while the United States and China are forecast to reach US$ million and US$ million by 2030, respectively. The proportion of the United States is % in 2023, while Chinese percentage is %, and it is predicted that China market share will reach % in 2030, trailing a CAGR of % through the analysis period. As for the Europe Companion Animal Specialty Drugs landscape, Germany is projected to reach US$ million by 2030. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

The Americas has the presence of large veterinary markets such as the US and Canada. The companion animal specialty drugs market is witnessing continuous growth in the region due to the rising awareness and the availability of companion animal healthcare. Furthermore, the increase in disposable incomes of pet owners and economic development, will also contribute to the growth of the market in this region.

This report focuses on Companion Animal Specialty Drugs volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Companion Animal Specialty Drugs market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.

Global Companion Animal Specialty Drugs Market: Segment Analysis

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

Vaccines

Antibiotics

Parasiticides

Feed Additives

Other

Segment by Application

Veterinary Hospitals

Pet Care Clinics

Pharmacy Stores

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

By Company

Bayer

Elanco

Merial

Zoetis

Aratana therapeutics

Beaphar

Henry Schein

Mars

The J.M Smucker Company

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Companion Animal Specialty Drugs product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Companion Animal Specialty Drugs, with price, sales, revenue, and global market share of Companion Animal Specialty Drugs from 2019 to 2022.

Chapter 3, the Companion Animal Specialty Drugs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Companion Animal Specialty Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Companion Animal Specialty Drugs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Companion Animal Specialty Drugs.

Chapter 13, 14, and 15, to describe Companion Animal Specialty Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Companion Animal Specialty Drugs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global Companion Animal Specialty Drugs Market Research Report 2023
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 86 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Companion Animal Specialty Drugs Market Overview
1.1 Product Overview and Scope of Companion Animal Specialty Drugs
1.2 Companion Animal Specialty Drugs Segment by Type
1.2.1 Global Companion Animal Specialty Drugs Sales Growth Rate Comparison by Type (2023-2030)
1.2.2 Vaccines
1.2.3 Antibiotics
1.2.4 Parasiticides
1.2.5 Feed Additives
1.2.6 Other
1.3 Companion Animal Specialty Drugs Segment by Application
1.3.1 Global Companion Animal Specialty Drugs Sales Comparison by Application: (2023-2030)
1.3.2 Veterinary Hospitals
1.3.3 Pet Care Clinics
1.3.4 Pharmacy Stores
1.4 Global Companion Animal Specialty Drugs Market Size Estimates and Forecasts
1.4.1 Global Companion Animal Specialty Drugs Revenue 2017-2030
1.4.2 Global Companion Animal Specialty Drugs Sales 2017-2030
1.4.3 Companion Animal Specialty Drugs Market Size by Region: 2017 Versus 2022 Versus 2030
2 Companion Animal Specialty Drugs Market Competition by Manufacturers
2.1 Global Companion Animal Specialty Drugs Sales Market Share by Manufacturers (2017-2023)
2.2 Global Companion Animal Specialty Drugs Revenue Market Share by Manufacturers (2017-2023)
2.3 Global Companion Animal Specialty Drugs Average Price by Manufacturers (2017-2023)
2.4 Manufacturers Companion Animal Specialty Drugs Manufacturing Sites, Area Served, Product Type
2.5 Companion Animal Specialty Drugs Market Competitive Situation and Trends
2.5.1 Companion Animal Specialty Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Companion Animal Specialty Drugs Players Market Share by Revenue
2.5.3 Global Companion Animal Specialty Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Companion Animal Specialty Drugs Retrospective Market Scenario by Region
3.1 Global Companion Animal Specialty Drugs Retrospective Market Scenario in Sales by Region: 2017-2023
3.2 Global Companion Animal Specialty Drugs Retrospective Market Scenario in Revenue by Region: 2017-2023
3.3 North America Companion Animal Specialty Drugs Market Facts & Figures by Country
3.3.1 North America Companion Animal Specialty Drugs Sales by Country
3.3.2 North America Companion Animal Specialty Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Companion Animal Specialty Drugs Market Facts & Figures by Country
3.4.1 Europe Companion Animal Specialty Drugs Sales by Country
3.4.2 Europe Companion Animal Specialty Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Companion Animal Specialty Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Companion Animal Specialty Drugs Sales by Region
3.5.2 Asia Pacific Companion Animal Specialty Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Companion Animal Specialty Drugs Market Facts & Figures by Country
3.6.1 Latin America Companion Animal Specialty Drugs Sales by Country
3.6.2 Latin America Companion Animal Specialty Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Companion Animal Specialty Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Companion Animal Specialty Drugs Sales by Country
3.7.2 Middle East and Africa Companion Animal Specialty Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Companion Animal Specialty Drugs Historic Market Analysis by Type
4.1 Global Companion Animal Specialty Drugs Sales Market Share by Type (2017-2023)
4.2 Global Companion Animal Specialty Drugs Revenue Market Share by Type (2017-2023)
4.3 Global Companion Animal Specialty Drugs Price by Type (2017-2023)
5 Global Companion Animal Specialty Drugs Historic Market Analysis by Application
5.1 Global Companion Animal Specialty Drugs Sales Market Share by Application (2017-2023)
5.2 Global Companion Animal Specialty Drugs Revenue Market Share by Application (2017-2023)
5.3 Global Companion Animal Specialty Drugs Price by Application (2017-2023)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Corporation Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Companion Animal Specialty Drugs Sales, Revenue and Gross Margin (2017-2023)
6.1.4 Bayer Companion Animal Specialty Drugs Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Elanco
6.2.1 Elanco Corporation Information
6.2.2 Elanco Description and Business Overview
6.2.3 Elanco Companion Animal Specialty Drugs Sales, Revenue and Gross Margin (2017-2023)
6.2.4 Elanco Companion Animal Specialty Drugs Product Portfolio
6.2.5 Elanco Recent Developments/Updates
6.3 Merial
6.3.1 Merial Corporation Information
6.3.2 Merial Description and Business Overview
6.3.3 Merial Companion Animal Specialty Drugs Sales, Revenue and Gross Margin (2017-2023)
6.3.4 Merial Companion Animal Specialty Drugs Product Portfolio
6.3.5 Merial Recent Developments/Updates
6.4 Zoetis
6.4.1 Zoetis Corporation Information
6.4.2 Zoetis Description and Business Overview
6.4.3 Zoetis Companion Animal Specialty Drugs Sales, Revenue and Gross Margin (2017-2023)
6.4.4 Zoetis Companion Animal Specialty Drugs Product Portfolio
6.4.5 Zoetis Recent Developments/Updates
6.5 Aratana therapeutics
6.5.1 Aratana therapeutics Corporation Information
6.5.2 Aratana therapeutics Description and Business Overview
6.5.3 Aratana therapeutics Companion Animal Specialty Drugs Sales, Revenue and Gross Margin (2017-2023)
6.5.4 Aratana therapeutics Companion Animal Specialty Drugs Product Portfolio
6.5.5 Aratana therapeutics Recent Developments/Updates
6.6 Beaphar
6.6.1 Beaphar Corporation Information
6.6.2 Beaphar Description and Business Overview
6.6.3 Beaphar Companion Animal Specialty Drugs Sales, Revenue and Gross Margin (2017-2023)
6.6.4 Beaphar Companion Animal Specialty Drugs Product Portfolio
6.6.5 Beaphar Recent Developments/Updates
6.7 Henry Schein
6.6.1 Henry Schein Corporation Information
6.6.2 Henry Schein Description and Business Overview
6.6.3 Henry Schein Companion Animal Specialty Drugs Sales, Revenue and Gross Margin (2017-2023)
6.4.4 Henry Schein Companion Animal Specialty Drugs Product Portfolio
6.7.5 Henry Schein Recent Developments/Updates
6.8 Mars
6.8.1 Mars Corporation Information
6.8.2 Mars Description and Business Overview
6.8.3 Mars Companion Animal Specialty Drugs Sales, Revenue and Gross Margin (2017-2023)
6.8.4 Mars Companion Animal Specialty Drugs Product Portfolio
6.8.5 Mars Recent Developments/Updates
6.9 The J.M Smucker Company
6.9.1 The J.M Smucker Company Corporation Information
6.9.2 The J.M Smucker Company Description and Business Overview
6.9.3 The J.M Smucker Company Companion Animal Specialty Drugs Sales, Revenue and Gross Margin (2017-2023)
6.9.4 The J.M Smucker Company Companion Animal Specialty Drugs Product Portfolio
6.9.5 The J.M Smucker Company Recent Developments/Updates
7 Companion Animal Specialty Drugs Manufacturing Cost Analysis
7.1 Companion Animal Specialty Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Companion Animal Specialty Drugs
7.4 Companion Animal Specialty Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Companion Animal Specialty Drugs Distributors List
8.3 Companion Animal Specialty Drugs Customers
9 Companion Animal Specialty Drugs Market Dynamics
9.1 Companion Animal Specialty Drugs Industry Trends
9.2 Companion Animal Specialty Drugs Market Drivers
9.3 Companion Animal Specialty Drugs Market Challenges
9.4 Companion Animal Specialty Drugs Market Restraints
10 Global Market Forecast
10.1 Companion Animal Specialty Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Companion Animal Specialty Drugs by Type (2023-2030)
10.1.2 Global Forecasted Revenue of Companion Animal Specialty Drugs by Type (2023-2030)
10.2 Companion Animal Specialty Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Companion Animal Specialty Drugs by Application (2023-2030)
10.2.2 Global Forecasted Revenue of Companion Animal Specialty Drugs by Application (2023-2030)
10.3 Companion Animal Specialty Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Companion Animal Specialty Drugs by Region (2023-2030)
10.3.2 Global Forecasted Revenue of Companion Animal Specialty Drugs by Region (2023-2030)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Companion Animal Specialty Drugs Sales Growth Rate Comparison by Type (2023-2030) & (K Units) & (US$ Million)
Table 2. Global Companion Animal Specialty Drugs Sales Growth Rate Comparison by Application (2023-2030) & (K Units) & (US$ Million)
Table 3. Global Companion Animal Specialty Drugs Market Size by Region (US$ Million) (2017 VS 2022 VS 2030)
Table 4. Global Companion Animal Specialty Drugs Market Competitive Situation by Manufacturers in 2022
Table 5. Global Companion Animal Specialty Drugs Sales (K Units) of Key Manufacturers (2017-2023)
Table 6. Global Companion Animal Specialty Drugs Sales Market Share by Manufacturers (2017-2023)
Table 7. Global Companion Animal Specialty Drugs Revenue (US$ Million) by Manufacturers (2017-2023)
Table 8. Global Companion Animal Specialty Drugs Revenue Share by Manufacturers (2017-2023)
Table 9. Global Market Companion Animal Specialty Drugs Average Price (USD/Unit) of Key Manufacturers (2017-2023)
Table 10. Manufacturers Companion Animal Specialty Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Companion Animal Specialty Drugs Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Companion Animal Specialty Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Companion Animal Specialty Drugs as of 2022)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Companion Animal Specialty Drugs Sales by Region (2017-2023) & (K Units)
Table 16. Global Companion Animal Specialty Drugs Sales Market Share by Region (2017-2023)
Table 17. Global Companion Animal Specialty Drugs Revenue by Region (2017-2023) & (US$ Million)
Table 18. Global Companion Animal Specialty Drugs Revenue Market Share by Region (2017-2023)
Table 19. North America Companion Animal Specialty Drugs Sales by Country (2017-2023) & (K Units)
Table 20. North America Companion Animal Specialty Drugs Sales Market Share by Country (2017-2023)
Table 21. North America Companion Animal Specialty Drugs Revenue by Country (2017-2023) & (US$ Million)
Table 22. North America Companion Animal Specialty Drugs Revenue Market Share by Country (2017-2023)
Table 23. Europe Companion Animal Specialty Drugs Sales by Country (2017-2023) & (K Units)
Table 24. Europe Companion Animal Specialty Drugs Sales Market Share by Country (2017-2023)
Table 25. Europe Companion Animal Specialty Drugs Revenue by Country (2017-2023) & (US$ Million)
Table 26. Europe Companion Animal Specialty Drugs Revenue Market Share by Country (2017-2023)
Table 27. Asia Pacific Companion Animal Specialty Drugs Sales by Region (2017-2023) & (K Units)
Table 28. Asia Pacific Companion Animal Specialty Drugs Sales Market Share by Region (2017-2023)
Table 29. Asia Pacific Companion Animal Specialty Drugs Revenue by Region (2017-2023) & (US$ Million)
Table 30. Asia Pacific Companion Animal Specialty Drugs Revenue Market Share by Region (2017-2023)
Table 31. Latin America Companion Animal Specialty Drugs Sales by Country (2017-2023) & (K Units)
Table 32. Latin America Companion Animal Specialty Drugs Sales Market Share by Country (2017-2023)
Table 33. Latin America Companion Animal Specialty Drugs Revenue by Country (2017-2023) & (US$ Million)
Table 34. Latin America Companion Animal Specialty Drugs Revenue Market Share by Country (2017-2023)
Table 35. Middle East and Africa Companion Animal Specialty Drugs Sales by Country (2017-2023) & (K Units)
Table 36. Middle East and Africa Companion Animal Specialty Drugs Sales Market Share by Country (2017-2023)
Table 37. Middle East and Africa Companion Animal Specialty Drugs Revenue by Country (2017-2023) & (US$ Million)
Table 38. Middle East and Africa Companion Animal Specialty Drugs Revenue Market Share by Country (2017-2023)
Table 39. Global Companion Animal Specialty Drugs Sales by Type (2017-2023) & (K Units)
Table 40. Global Companion Animal Specialty Drugs Sales Market Share by Type (2017-2023)
Table 41. Global Companion Animal Specialty Drugs Revenue by Type (2017-2023) & (US$ Million)
Table 42. Global Companion Animal Specialty Drugs Revenue Share by Type (2017-2023)
Table 43. Global Companion Animal Specialty Drugs Price by Type (2017-2023) & (USD/Unit)
Table 44. Global Companion Animal Specialty Drugs Sales (K Units) by Application (2017-2023)
Table 45. Global Companion Animal Specialty Drugs Sales Market Share by Application (2017-2023)
Table 46. Global Companion Animal Specialty Drugs Revenue by Application (2017-2023) & (US$ Million)
Table 47. Global Companion Animal Specialty Drugs Revenue Share by Application (2017-2023)
Table 48. Global Companion Animal Specialty Drugs Price by Application (2017-2023) & (USD/Unit)
Table 49. Bayer Corporation Information
Table 50. Bayer Description and Business Overview
Table 51. Bayer Companion Animal Specialty Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2023)
Table 52. Bayer Companion Animal Specialty Drugs Product
Table 53. Bayer Recent Developments/Updates
Table 54. Elanco Corporation Information
Table 55. Elanco Description and Business Overview
Table 56. Elanco Companion Animal Specialty Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2023)
Table 57. Elanco Companion Animal Specialty Drugs Product
Table 58. Elanco Recent Developments/Updates
Table 59. Merial Corporation Information
Table 60. Merial Description and Business Overview
Table 61. Merial Companion Animal Specialty Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2023)
Table 62. Merial Companion Animal Specialty Drugs Product
Table 63. Merial Recent Developments/Updates
Table 64. Zoetis Corporation Information
Table 65. Zoetis Description and Business Overview
Table 66. Zoetis Companion Animal Specialty Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2023)
Table 67. Zoetis Companion Animal Specialty Drugs Product
Table 68. Zoetis Recent Developments/Updates
Table 69. Aratana therapeutics Corporation Information
Table 70. Aratana therapeutics Description and Business Overview
Table 71. Aratana therapeutics Companion Animal Specialty Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2023)
Table 72. Aratana therapeutics Companion Animal Specialty Drugs Product
Table 73. Aratana therapeutics Recent Developments/Updates
Table 74. Beaphar Corporation Information
Table 75. Beaphar Description and Business Overview
Table 76. Beaphar Companion Animal Specialty Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2023)
Table 77. Beaphar Companion Animal Specialty Drugs Product
Table 78. Beaphar Recent Developments/Updates
Table 79. Henry Schein Corporation Information
Table 80. Henry Schein Description and Business Overview
Table 81. Henry Schein Companion Animal Specialty Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2023)
Table 82. Henry Schein Companion Animal Specialty Drugs Product
Table 83. Henry Schein Recent Developments/Updates
Table 84. Mars Corporation Information
Table 85. Mars Description and Business Overview
Table 86. Mars Companion Animal Specialty Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2023)
Table 87. Mars Companion Animal Specialty Drugs Product
Table 88. Mars Recent Developments/Updates
Table 89. The J.M Smucker Company Corporation Information
Table 90. The J.M Smucker Company Description and Business Overview
Table 91. The J.M Smucker Company Companion Animal Specialty Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2023)
Table 92. The J.M Smucker Company Companion Animal Specialty Drugs Product
Table 93. The J.M Smucker Company Recent Developments/Updates
Table 94. Production Base and Market Concentration Rate of Raw Material
Table 95. Key Suppliers of Raw Materials
Table 96. Companion Animal Specialty Drugs Distributors List
Table 97. Companion Animal Specialty Drugs Customers List
Table 98. Companion Animal Specialty Drugs Market Trends
Table 99. Companion Animal Specialty Drugs Market Drivers
Table 100. Companion Animal Specialty Drugs Market Challenges
Table 101. Companion Animal Specialty Drugs Market Restraints
Table 102. Global Companion Animal Specialty Drugs Sales Forecast by Type (2023-2030) & (K Units)
Table 103. Global Companion Animal Specialty Drugs Sales Market Share Forecast by Type (2023-2030)
Table 104. Global Companion Animal Specialty Drugs Revenue Forecast by Type (2023-2030) & (US$ Million)
Table 105. Global Companion Animal Specialty Drugs Revenue Market Share Forecast by Type (2023-2030)
Table 106. Global Companion Animal Specialty Drugs Sales Forecast by Application (2023-2030) & (K Units)
Table 107. Global Companion Animal Specialty Drugs Sales Market Share Forecast by Application (2023-2030)
Table 108. Global Companion Animal Specialty Drugs Revenue Forecast by Application (2023-2030) & (US$ Million)
Table 109. Global Companion Animal Specialty Drugs Revenue Market Share Forecast by Application (2023-2030)
Table 110. Global Companion Animal Specialty Drugs Sales Forecast by Region (2023-2030) & (K Units)
Table 111. Global Companion Animal Specialty Drugs Sales Market Share Forecast by Region (2023-2030)
Table 112. Global Companion Animal Specialty Drugs Revenue Forecast by Region (2023-2030) & (US$ Million)
Table 113. Global Companion Animal Specialty Drugs Revenue Market Share Forecast by Region (2023-2030)
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Companion Animal Specialty Drugs
Figure 2. Global Companion Animal Specialty Drugs Market Share by Type in 2022 & 2030
Figure 3. Vaccines Product Picture
Figure 4. Antibiotics Product Picture
Figure 5. Parasiticides Product Picture
Figure 6. Feed Additives Product Picture
Figure 7. Other Product Picture
Figure 8. Global Companion Animal Specialty Drugs Market Share by Application in 2022 & 2030
Figure 9. Veterinary Hospitals
Figure 10. Pet Care Clinics
Figure 11. Pharmacy Stores
Figure 12. Global Companion Animal Specialty Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2030
Figure 13. Global Companion Animal Specialty Drugs Market Size (2017-2030) & (US$ Million)
Figure 14. Global Companion Animal Specialty Drugs Sales (2017-2030) & (K Units)
Figure 15. Companion Animal Specialty Drugs Sales Share by Manufacturers in 2022
Figure 16. Global Companion Animal Specialty Drugs Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Companion Animal Specialty Drugs Players: Market Share by Revenue in 2022
Figure 18. Companion Animal Specialty Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2022
Figure 19. Global Companion Animal Specialty Drugs Sales Market Share by Region (2017-2023)
Figure 20. Global Companion Animal Specialty Drugs Sales Market Share by Region in 2022
Figure 21. Global Companion Animal Specialty Drugs Revenue Market Share by Region (2017-2023)
Figure 22. Global Companion Animal Specialty Drugs Revenue Market Share by Region in 2022
Figure 23. U.S. Companion Animal Specialty Drugs Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 24. Canada Companion Animal Specialty Drugs Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 25. Germany Companion Animal Specialty Drugs Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 26. France Companion Animal Specialty Drugs Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 27. U.K. Companion Animal Specialty Drugs Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 28. Italy Companion Animal Specialty Drugs Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 29. Russia Companion Animal Specialty Drugs Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 30. China Companion Animal Specialty Drugs Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 31. Japan Companion Animal Specialty Drugs Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 32. South Korea Companion Animal Specialty Drugs Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 33. India Companion Animal Specialty Drugs Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 34. Australia Companion Animal Specialty Drugs Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 35. Taiwan Companion Animal Specialty Drugs Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 36. Indonesia Companion Animal Specialty Drugs Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 37. Thailand Companion Animal Specialty Drugs Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 38. Malaysia Companion Animal Specialty Drugs Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 39. Philippines Companion Animal Specialty Drugs Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 40. Vietnam Companion Animal Specialty Drugs Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 41. Mexico Companion Animal Specialty Drugs Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 42. Brazil Companion Animal Specialty Drugs Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 43. Argentina Companion Animal Specialty Drugs Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 44. Turkey Companion Animal Specialty Drugs Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 45. Saudi Arabia Companion Animal Specialty Drugs Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 46. UAE Companion Animal Specialty Drugs Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 47. Sales Market Share of Companion Animal Specialty Drugs by Type (2017-2023)
Figure 48. Manufacturing Cost Structure of Companion Animal Specialty Drugs
Figure 49. Manufacturing Process Analysis of Companion Animal Specialty Drugs
Figure 50. Companion Animal Specialty Drugs Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount